» Articles » PMID: 25177413

Is There Chronic Brain Damage in Retired NFL Players? Neuroradiology, Neuropsychology, and Neurology Examinations of 45 Retired Players

Overview
Journal Sports Health
Publisher Sage Publications
Specialty Orthopedics
Date 2014 Sep 2
PMID 25177413
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Neuropathology and surveys of retired National Football League (NFL) players suggest that chronic brain damage is a frequent result of a career in football. There is limited information on the neurological statuses of living retired players. This study aimed to fill the gap in knowledge by conducting in-depth neurological examinations of 30- to 60-year-old retired NFL players.

Hypothesis: In-depth neurological examinations of 30- to 60-year-old retired players are unlikely to detect objective clinical abnormalities in the majority of subjects.

Study Design: A day-long medical examination was conducted on 45 retired NFL players, including state-of-the-art magnetic resonance imaging (MRI; susceptibility weighted imaging [SWI], diffusion tensor imaging [DTI]), comprehensive neuropsychological and neurological examinations, interviews, blood tests, and APOE (apolipoprotein E) genotyping.

Level Of Evidence: Level 3.

Methods: Participants' histories focused on neurological and depression symptoms, exposure to football, and other factors that could affect brain function. The neurological examination included Mini-Mental State Examination (MMSE) evaluation of cognitive function and a comprehensive search for signs of dysarthria, pyramidal system dysfunction, extrapyramidal system dysfunction, and cerebellar dysfunction. The Beck Depression Inventory (BDI) and Patient Health Questionnaire (PHQ) measured depression. Neuropsychological tests included pen-and-paper and ImPACT evaluation of cognitive function. Anatomical examination SWI and DTI MRI searched for brain injuries. The results were statistically analyzed for associations with markers of exposure to football and related factors, such as body mass index (BMI), ethanol use, and APOE4 status.

Results: The retired players' ages averaged 45.6 ± 8.9 years (range, 30-60 years), and they had 6.8 ± 3.2 years (maximum, 14 years) of NFL play. They reported 6.9 ± 6.2 concussions (maximum, 25) in the NFL. The majority of retired players had normal clinical mental status and central nervous system (CNS) neurological examinations. Four players (9%) had microbleeds in brain parenchyma identified in SWI, and 3 (7%) had a large cavum septum pellucidum with brain atrophy. The number of concussions/dings was associated with abnormal results in SWI and DTI. Neuropsychological testing revealed isolated impairments in 11 players (24%), but none had dementia. Nine players (20%) endorsed symptoms of moderate or severe depression on the BDI and/or met criteria for depression on PHQ; however, none had dementia, dysarthria, parkinsonism, or cerebellar dysfunction. The number of football-related concussions was associated with isolated abnormalities on the clinical neurological examination, suggesting CNS dysfunction. The APOE4 allele was present in 38% of the players, a larger number than would be expected in the general male population (23%-26%).

Conclusion: MRI lesions and neuropsychological impairments were found in some players; however, the majority of retired NFL players had no clinical signs of chronic brain damage.

Clinical Relevance: These results need to be reconciled with the prevailing view that a career in football frequently results in chronic brain damage.

Citing Articles

Inferring neurocognition using artificial intelligence on brain MRIs.

Hussain M, Grant P, Ou Y Front Neuroimaging. 2024; 3:1455436.

PMID: 39664769 PMC: 11631947. DOI: 10.3389/fnimg.2024.1455436.


Using the NINDS Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome on 4 Cohorts of Retired Contact Sport Athletes.

Casson I, Viano D Sports Health. 2022; 15(6):842-847.

PMID: 36517991 PMC: 10606970. DOI: 10.1177/19417381221139259.


Cerebral and cognitive modifications in retired professional soccer players: TC-FOOT protocol, a transverse analytical study.

Kepka S, Lersy F, Godet J, Blanc F, Bilger M, Botzung A BMJ Open. 2022; 12(11):e060459.

PMID: 36351716 PMC: 9664284. DOI: 10.1136/bmjopen-2021-060459.


Gender and Workplace Stress Affect the Association Between Concussion History and Depression Symptoms in Professional Jockeys.

Piantella S, McDonald S, Wright B Arch Clin Neuropsychol. 2022; 38(4):537-547.

PMID: 36309850 PMC: 10202554. DOI: 10.1093/arclin/acac084.


Multi-modality human phenotyping to examine subjective and objective health afflictions in former professional American-style football players: The In-Person Assessment (IPA) protocol.

Cortez B, Valdivia C, Keating D, Marengi D, Bates T, Brown C PLoS One. 2022; 17(3):e0265737.

PMID: 35358242 PMC: 8970522. DOI: 10.1371/journal.pone.0265737.


References
1.
Giza C, Kutcher J, Ashwal S, Barth J, Getchius T, Gioia G . Summary of evidence-based guideline update: evaluation and management of concussion in sports: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013; 80(24):2250-7. PMC: 3721093. DOI: 10.1212/WNL.0b013e31828d57dd. View

2.
Westlye L, Reinvang I, Rootwelt H, Espeseth T . Effects of APOE on brain white matter microstructure in healthy adults. Neurology. 2012; 79(19):1961-9. DOI: 10.1212/WNL.0b013e3182735c9c. View

3.
Friedman G, Froom P, Sazbon L, Grinblatt I, Shochina M, Tsenter J . Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology. 1999; 52(2):244-8. DOI: 10.1212/wnl.52.2.244. View

4.
Pellman E, Powell J, Viano D, Casson I, Tucker A, Feuer H . Concussion in professional football: epidemiological features of game injuries and review of the literature--part 3. Neurosurgery. 2003; 54(1):81-94. DOI: 10.1227/01.neu.0000097267.54786.54. View

5.
McCrory P, Collie A, Anderson V, Davis G . Can we manage sport related concussion in children the same as in adults?. Br J Sports Med. 2004; 38(5):516-9. PMC: 1724912. DOI: 10.1136/bjsm.2004.014811. View